[Homocysteine as risk marker of cardiovascular disease].

Basic research has demonstrated that homocysteine enhances both arteriosclerosis and thrombosis - the principal cause of CVD. Although studies demonstrate that patients with elevated homocysteine levels have small to moderate increased risk of CVD it remains unclear whether lowering plasma homocysteine levels will decrease risks of CVD. The study was aimed to detect reliability of homocysteine lowering on risk of CVD.

[Significance of homocysteines in the development of acute myocardial infarction].

The aim was the study of the connection of the changes in serum homocysteine concentration with acute myocardium infarction, in order to establish whether the increase in homocysteine concentration is one of the risk-factors in the development of the cardiac insufficiency. The patients with acute myocardial infarction were studied. The following tests were performed: determination of the homocysteine concentration in serum by ELISA; determination of the main characteristics of hemostasis by automatic coagulometer (AMELUNG); determination of lipid spectrum by biochemical analyzer (Johnson & Johnson Vitros DT).